These findings highlight circ-HACE1 as a promising target to enhance the diagnostic accuracy of COPD and suggest that inhibiting its expression could hold potential benefits in the therapeutic management of COPD. This evidence concerns the gene HACE1 and chronic obstructive pulmonary disease.